lobbying_filings_raw: 459d32bc-294b-42e6-b8a2-d09041ee162b
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 459d32bc-294b-42e6-b8a2-d09041ee162b | Q1 | 400531586 | CROSSROADS STRATEGIES, LLC | 192245 | SANOFI US SERVICES INC. | 2021 | first_quarter | 2021-04-19T11:13:01.700000-04:00 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/459d32bc-294b-42e6-b8a2-d09041ee162b/", "filing_uuid": "459d32bc-294b-42e6-b8a2-d09041ee162b", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2021, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/459d32bc-294b-42e6-b8a2-d09041ee162b/print/", "filing_document_content_type": "text/html", "income": "50000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "John Green", "dt_posted": "2021-04-19T11:13:01.700000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "800 North Capitol Street, NW, Suite 800", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20002", "registrant": {"id": 400531586, "url": "https://lda.senate.gov/api/v1/registrants/400531586/", "house_registrant_id": null, "name": "CROSSROADS STRATEGIES, LLC", "description": "lobbying firm", "address_1": "800 North Capitol Street, NW, Suite 800", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20002", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MATHEW LAPINSKI", "contact_telephone": "+1 202-559-0170", "dt_updated": "2026-01-30T13:29:06.487633-05:00"}, "client": {"id": 192245, "url": "https://lda.senate.gov/api/v1/clients/192245/", "client_id": 1193, "name": "SANOFI US SERVICES INC.", "general_description": "pharmaceutical manufacturer", "client_government_entity": false, "client_self_select": null, "state": "NJ", "state_display": "New Jersey", "country": "US", "country_display": "United States of America", "ppb_state": "NJ", "ppb_state_display": "New Jersey", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2018-02-01"}, "lobbying_activities": [{"general_issue_code": "TRD", "general_issue_code_display": "Trade (domestic/foreign)", "description": "Issues related to pharmaceutical IP and supply chain.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58561, "prefix": null, "prefix_display": null, "first_name": "MATHEW", "nickname": null, "middle_name": null, "last_name": "LAPINSKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66496, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": "BENJAMIN", "last_name": "VAN PELT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66518, "prefix": null, "prefix_display": null, "first_name": "SHAY", "nickname": null, "middle_name": "MICHAEL", "last_name": "HANCOCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 50936, "prefix": null, "prefix_display": null, "first_name": "HUNTER", "nickname": null, "middle_name": null, "last_name": "MOORHEAD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67932, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": null, "last_name": "GLEASON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 11, "name": "Executive Office of the President (EOP)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Biopharmaceutical innovation and patent policy issues.\nTrademark legislative proposals.\nBayh-Dole march-in rights policy issues.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58561, "prefix": null, "prefix_display": null, "first_name": "MATHEW", "nickname": null, "middle_name": null, "last_name": "LAPINSKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66496, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": "BENJAMIN", "last_name": "VAN PELT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66518, "prefix": null, "prefix_display": null, "first_name": "SHAY", "nickname": null, "middle_name": "MICHAEL", "last_name": "HANCOCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 50936, "prefix": null, "prefix_display": null, "first_name": "HUNTER", "nickname": null, "middle_name": null, "last_name": "MOORHEAD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67932, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": null, "last_name": "GLEASON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 11, "name": "Executive Office of the President (EOP)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Issues related to Rx-to-OTC switch issues, influenza, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program, and education around COVID-19 therapies.\nExecutive Order on Access to Affordable Life-saving Medications (E.O.13937); Executive Order on Increasing Drug Importation to Lower Prices for American Patients (E.O.13938); Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen (E.O.13939); Executive Orders on Lowering Drug Prices by Putting America First (E.O.13947, E.O.13948); Executive Order on Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States (E.O.13944); Executive Order on An America-First Healthcare Plan (E.O.13951). \nS.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58561, "prefix": null, "prefix_display": null, "first_name": "MATHEW", "nickname": null, "middle_name": null, "last_name": "LAPINSKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66496, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": "BENJAMIN", "last_name": "VAN PELT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66518, "prefix": null, "prefix_display": null, "first_name": "SHAY", "nickname": null, "middle_name": "MICHAEL", "last_name": "HANCOCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 50936, "prefix": null, "prefix_display": null, "first_name": "HUNTER", "nickname": null, "middle_name": null, "last_name": "MOORHEAD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67932, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": null, "last_name": "GLEASON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 11, "name": "Executive Office of the President (EOP)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap;\nH.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58561, "prefix": null, "prefix_display": null, "first_name": "MATHEW", "nickname": null, "middle_name": null, "last_name": "LAPINSKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66496, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": "BENJAMIN", "last_name": "VAN PELT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66518, "prefix": null, "prefix_display": null, "first_name": "SHAY", "nickname": null, "middle_name": "MICHAEL", "last_name": "HANCOCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 50936, "prefix": null, "prefix_display": null, "first_name": "HUNTER", "nickname": null, "middle_name": null, "last_name": "MOORHEAD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67932, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": null, "last_name": "GLEASON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 11, "name": "Executive Office of the President (EOP)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Issues related to related to appropriations, federal health programs and prescription drugs;\nFY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.R.748, CARES Act (P.L.116-136) implementation; H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58561, "prefix": null, "prefix_display": null, "first_name": "MATHEW", "nickname": null, "middle_name": null, "last_name": "LAPINSKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66496, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": "BENJAMIN", "last_name": "VAN PELT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66518, "prefix": null, "prefix_display": null, "first_name": "SHAY", "nickname": null, "middle_name": "MICHAEL", "last_name": "HANCOCK", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 50936, "prefix": null, "prefix_display": null, "first_name": "HUNTER", "nickname": null, "middle_name": null, "last_name": "MOORHEAD", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67932, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": null, "last_name": "GLEASON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 11, "name": "Executive Office of the President (EOP)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | NJ | NJ | US | US | pharmaceutical manufacturer | 0 | 0 | 50000.0 |